soblidotin

Source:http://linkedlifedata.com/resource/umls/id/C1328702

NCI: A substance being studied in the treatment of cancer. It is a type of tubulin inhibitor.,PDQ: A dolastatin-10 derivative. Soblidotin inhibits tubulin polymerization, resulting in cell cycle arrest and induction of apoptosis. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=302644&idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=302644&idtype=1&closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C26672" NCI Thesaurus),NCI: A dolastatin-10 derivative. Soblidotin inhibits tubulin polymerization, resulting in cell cycle arrest and induction of apoptosis. (NCI04)

Download in:

View as